Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 462 results for "warner chilcott"

Interested shoppers prompt Warner to weigh sale options

Warner Chilcott ($WCRX) is the latest drugmaker to stir up the M&A pot. The company is looking at its options, including a possible sale, Bloomberg reports, citing sources. Apparently, Warner started getting inquiries from private equity firms and ... FiercePharma, 1 month ago

Former Warner Chilcott Sales Manager Pleads Guilty to Conspiracy to Commit Health Care Fraud

BOSTON-A former district manager of Warner Chilcott Sales U.S., LLC (Warner Chilcott), a pharmaceutical company based in Rockaway, N.J., pleaded guilty today in U.S. District Court in Boston in connection with a scheme to deceive insurance companies ...
 Noodls1 month ago
Gastroenterology & Endoscopy News

Ulcerative Colitis: Diagnosis and Treatment

Ellen J. Scherl, MD Director, Jill Roberts Center for Inflammatory Bowel Diseasea Attending Physician a Professor of Clinical Medicine b Jill Roberts Professor of Inflammatory Bowel Diseaseb Adjunct Professor of Medicine c Brian P.
 Gastroenterology & Endoscopy News3 days ago
Citybizlist

Bain Capital Invests in QuVa Pharma

QuVa Pharma, Inc. , a newly formed national platform for sterile compounding pharmacy services led by two experienced industry executives, announces it has completed the acquisition of the assets of the 503B Compounding Pharmacy Services Division of ...
 Citybizlist4 days ago
Inside Counsel

A look at the post-Actavis landscape

We now look at where two years of antitrust litigation post-Actavis have left litigants and courts as they work through the implications of the case. Two years ago, the Supreme Court issued its decision in FTC v. Actavis, Inc., holding that patent ...
 Inside Counsel1 week ago A look at the post- Actavis landscape  Inside Counsel1 week ago
Canadian Business Journal

Cynapsus Therapeutics Reports Second Quarter 2015 Financial Results and Recent Developments

TORONTO, ONTARIO(Marketwired Aug. 14, 2015) - Cynapsus Therapeutics Inc. (NASDAQ:CYNA)(TSX:CTH) (Cynapsus or the Company), a specialty Central Nervous System (CNS) pharmaceutical company developing and preparing to commercialize a fast-acting, ...
 Canadian Business Journal2 weeks ago Paratek Pharmaceuticals to Present Data at ICAAC 2015  Industrial Info Financials3 weeks ago Paratek Pharmaceuticals to Report Second Quarter 2015 Financial Results on August 5, 2015  BioSpace1 month ago Paratek Pharmaceuticals : to Report Second Quarter 2015 Financial Results on August 5, 2015  4 Traders1 month ago
[x]  
Corporate Counsel

Playing (Paying) the Generics Game

Two years after the U.S. Supreme Court's landmark decision in Federal Trade Commission v. Actavis erected a roadblock against pharmaceutical firms paying competitors to delay bringing generics to market, appeals courts are extending it beyond cash ...
 Corporate Counsel2 weeks ago
Forbes.com

Ackman's 'wolf pack' drove Allergan into foreign hands, former CEO says

Allergan CEO David Pyott Former Allergan ( $AGN ) CEO David Pyott and activist investor Bill Ackman called each other plenty of things during last year's months-long Valeant-Allergan takeover battle. But Pyott had a new one during a Senate ...
 FiercePharma4 weeks ago Allergan's CEO On Selling His Generics Business  Forbes.com1 month ago
Nasdaq

Enzymotec Ltd. Announces the Appointment of Tamar Howson to Its Board of Directors

(GLOBE NEWSWIRE) -- . (Nasdaq:ENZY) (the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today the appointment of Tamar Howson to its Board of Directors, effective July 29, 2015. Steve Dubin, ...
 Wall Street Select4 weeks ago Enzymotec Announces The Appointment Of Tamar Howson To Its Board Of Directors  FierceBiotech4 weeks ago
[x]  
AdvisorOne

Valeant Tells Congress a Very Different Tax Tale Than Investors

When it goes before Congress on Thursday, Valeant Pharmaceuticals International Inc. will tell lawmakers that it doesn't consider tax savings when the company -- one of the industry's most acquisitive -- is making deals. Valeant does not take into ...
 Yahoo! Finance1 month ago Valeant Tells Congress a Different Tax Tale Than Investors  NewsMax.com4 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - warner chilcott
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less